Abstract
Aim
In the 7th edition of the TNM classification, not only HCC with distant metastases but also those with regional lymph node metastases are classified as stage IV.
Materials and methods, Results
From our prospectively recorded tumor registry, 138 patients (17 %) with HCC were in stage IV. Among those were 68 and 70, respectively, in stage IVA (regional lymph node metastases) and IVB (distant metastases). The tumors were less frequently treated with resection or local ablative treatment (chemoembolization, RFA, SIRT, percutaneous radiation) than patients in stage I–III. Ten HCCs were resected. Five of the resected patients were in stage IVA and five in stage IVB. After tumor resection, patients lived longer than those who underwent local or systemic treatment only (p = 0.003 or p = 0.001, respectively). In the univariate survival analysis, the stage IV patients’ long-term survival was decreased statistically significantly through elevated bilirubin, low albumin, Okuda stage III and BCLC stage D. Patients’ age and sex, pre-treatment AFP level, Child stage and the presence of venous invasion did not influence survival. In the multivariate analysis (Cox regression), tumor resection and BCLC stage were independent prognostic factors.
Conclusion
Patients with HCC in TNM stage IV have a very poor prognosis. Only few patients are eligible for resection because of the extent of tumor growth, comorbidities and general condition. These, however, benefit markedly from tumor resection with lymph node dissection and possibly resection of distant metastases.
Similar content being viewed by others
References
Changchien CS, Chen CL, Yen YH, Wang JH, Hu TH, Lee CM, Wang CC, Cheng YF, Huang YJ, Lin CY, Lu SN (2008) Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol 43(2):159–170. doi:10.1007/s00535-007-2134-9
Chen YX, Zeng ZC, Fan J, Tang ZY, Zhou J, Zeng MS, Zhang JY, Sun J (2013) Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases. Clin Transl Oncol 15(9):732–740. doi:10.1007/s12094-012-0997-6
Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. Springer, New York
Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jarnagin WR (2006) Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244(2):260–264. doi:10.1097/01.sla.0000217606.59625.9d
Han KN, Kim YT, Yoon JH, Suh KS, Song JY, Kang CH, Sung SW, Kim JH (2010) Role of surgical resection for pulmonary metastasis of hepatocellular carcinoma. Lung Cancer 70(3):295–300. doi:10.1016/j.lungcan.2010.02.014
Kee KM, Wang JH, Lin CY, Wang CC, Cheng YF, Lu SN (2013) Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center. Dig Dis Sci 58(9):2721–2728. doi:10.1007/s10620-013-2716-8
Kitano K, Murayama T, Sakamoto M, Nagayama K, Ueno K, Murakawa T, Nakajima J (2012) Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma. Eur J Cardiothorac Surg 41(2):376–382. doi:10.1016/j.ejcts.2011.05.052
Lee CW, Chan KM, Lee CF, Yu MC, Lee WC, Wu TJ, Chen MF (2011) Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg 34(2):53–62. doi:10.1016/S1015-9584(11)60020-1
Llovet JM, Lencioni R, Di Bisceglie AM, Gaile PR, Dufour JF, Greten TF, Raymond E, Roskams T, De Baere T, Ducreux M, Mazzaferro V, Bernardi M, Bruix J, Colombo M, Zhu A, Liver EAS, Liver EAS, Canc EORT (2012) EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943
Malek NP, Schmidt S, Huber P, Manns MP, Greten TF (2014) The diagnosis and treatment of hepatocellular carcinoma. Dtsch Arzteblatt Int 111(7):101–106. doi:10.3238/arztebl.2014.0101
Ravaioli M, Ercolani G, Grazi GL, Cescon M, Dazzi A, Zanfi C, Pinna AD (2010) Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. Updates Surg 62(1):27–34. doi:10.1007/s13304-010-0008-9
Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, Schwartz M, Han G, Izzo F, Chen M, Blanc JF, Johnson P, Kudo M, Roberts LR, Sherman M (2015) The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62(2):440–451. doi:10.1002/hep.27745
Sano T, Izuishi K, Takebayashi R, Akamoto S, Kakinoki K, Okano K, Masaki T, Suzuki Y (2011) Surgical approach for extrahepatic metastasis of HCC in the abdominal cavity. Hepatogastroenterology 58(112):2067–2070. doi:10.5754/hge11188
Schmidt F, Senninger N, Wolters HH, Mees ST (2014) Advances, limitations and prospects of oncological liver surgery. Zent Chir 139(2):203–211. doi:10.1055/s-0033-1350815
Shen XH, Li HK, Wang F, Zhang T, Cui YL, Li Q (2010) Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg 34(5):1028–1033. doi:10.1007/s00268-010-0400-0
Slotta JE, Kollmar O, Ellenrieder V, Ghadimi BM, Homayounfar K (2015) Hepatocellular carcinoma: surgeon’s view on latest findings and future perspectives. World J Hepatol 7(9):1168–1183. doi:10.4254/wjh.v7.i9.1168
Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer (2010) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Chichester
Sun HC, Zhuang PY, Qin LX, Ye QH, Wang L, Ren N, Zhang JB, Qian YB, Lu L, Fan J, Tang ZY (2007) Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol 96(1):37–45. doi:10.1002/jso.20772
Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, Makuuchi M (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group. Ann Surg 257(5):929–937. doi:10.1097/SLA.0b013e31828329b8
Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, Hiramatsu A, Kodama H, Takahashi S, Chayama K (2007) Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 13(3):414–420
Watanabe J, Nakashima O, Kojiro M (1994) Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Clin Oncol 24(1):37–41
Wu X, Li B, Qiu J, Shen J, Zheng Y, Li Q, Liao Y, He W, Zou R, Yuan Y (2015) Hepatectomy versus hepatectomy with lymphadenectomy in hepatocellular carcinoma: a prospective, randomized controlled clinical trial. J Clin Gastroenterol 49(6):520–528. doi:10.1097/MCG.0000000000000277
Xia F, Wu L, Lau WY, Li G, Huan HB, Qian C, Ma KS, Bie P (2014) Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One. doi:10.1371/journal.pone.0095889
Xiaohong S, Huikai L, Feng W, Ti Z, Yunlong C, Qiang L (2010) Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg 34(5):1028–1033. doi:10.1007/s00268-010-0400-0
Yang T, Lu JH, Lin C, Shi S, Chen TH, Zhao RH, Wang Y, Wu MC (2012) Concomitant lung metastasis in patients with advanced hepatocellular carcinoma. World J Gastroenterol 18(20):2533–2539. doi:10.3748/wjg.v18.i20.2533
Yang T, Lau WY, Zhang H, Huang B, Lu JH, Wu MC (2015) Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: surgeons’ perspective. World J Gastroenterol 21(27):8256–8261. doi:10.3748/wjg.v21.i27.8256
Yoo DJ, Kim KM, Jin YJ, Shim JH, Ko GY, Yoon HK, Sung KB, Lee JL, Kang YK, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ (2011) Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients? J Gastroenterol Hepatol 26(1):145–154. doi:10.1111/j.1440-1746.2010.06341.x
Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y (1990) Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 66(10):2174–2179
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical standard
The retrospective study was in accordance with the ethical standards of the Helsinki declaration.
Funding
No external funding was provided for this work.
Informed consent
All patients give their consent for clinical registration. We have only used data from the clinical data registry.
Rights and permissions
About this article
Cite this article
Bauschke, A., Altendorf-Hofmann, A., Malessa, C. et al. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?. J Cancer Res Clin Oncol 142, 2593–2601 (2016). https://doi.org/10.1007/s00432-016-2260-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-016-2260-y